Every material Form 8-K Xos, Inc. has filed with the SEC since May 14, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Xos reported second-quarter 2026 revenue of $4.7 million, down from $18.4 million a year earlier, while gross margin rose to 12.1% and net loss narrowed to $6.9 million. The company is revising its 2026 outlook, citing shifted second-half product mix and volume, and says second-quarter deliveries moved into later quarters.
Q2 2026 revenue was $4.7 million on 30 units, versus $18.4 million on 135 units in Q2 2025
Q2 2026 net loss was $6.9 million, compared with $7.5 million in Q2 2025; GAAP operating loss widened to $7.9 million from $7.1 million
Revised 2026 outlook: revenue of $35 to $43 million, non-GAAP operating loss of $(14.7) million to $(11.4) million, and 250 to 350 unit deliveries
Cash and cash equivalents were $13.2 million at June 30, 2026, up from $9.8 million at March 31, 2026
Xos, Inc. sold 1,090,910 shares of common stock at $5.50 per share in a registered direct offering, for approximately $6.0 million in gross proceeds before placement agent fees and offering expenses. The sale was completed on June 5, 2026, under an existing shelf registration, so it adds new shares outstanding and provides cash to the company.
Shares sold at $5.50 each, 1,090,910 shares, approximately $6.0 million gross proceeds
Agreements dated June 4, 2026; sale completed June 5, 2026
Roth Capital Partners acted as exclusive placement agent, with a cash fee of 6.5% of gross proceeds plus up to $75,000 in expenses
Xos reported first-quarter 2026 revenue of $11.2 million, up from $5.9 million a year earlier, with gross margin rising to 38.6% from 20.6% and the operating loss falling to $4.7 million from $9.3 million. The company maintained its full-year 2026 outlook of $40.0 to $50.0 million in revenue and 350 to 500 units delivered, and its non-GAAP operating loss outlook of $11.9 to $13.3 million.
Q1 2026 revenue was $11.2 million versus $5.9 million in Q1 2025; units delivered were 95 versus 29.
Gross margin was 38.6% versus 20.6%; net loss narrowed to $5.0 million from $10.2 million.
Cash and cash equivalents were $9.8 million at March 31, 2026, down from $14.0 million at December 31, 2025.
2026 outlook was maintained: revenue of $40.0 to $50.0 million and 350 to 500 units.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Xos, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →